en
svPress releases
Regulatory press release 2023-02-15
Interim Report Fourth Quarter 2022
Regulatory press release 2022-11-09
Interim Report Third Quarter 2022
Regulatory press release 2022-10-31
Number of shares and votes in Xspray Pharma
Regulatory press release 2022-10-25
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2023
Regulatory press release 2022-10-17
Xspray Pharma has carried out a directed share issue raising proceeds of MSEK 100
Regulatory press release 2022-08-05
Interim Report Second Quarter 2022
Regulatory press release 2022-06-17
Dasynoc granted Orphan Drug Designation in the US for the treatment of chronic myeloid leukemia
Regulatory press release 2022-06-15
Xspray Pharma appoints Thomas Walz as Chief Medical Officer
Regulatory press release 2022-05-19
Bulletin from the 2022 Annual General Meeting of Xspray Pharma AB (publ)
Regulatory press release 2022-05-06